Analyze Diet

Topic:Medication

The topic of medication in horses encompasses the study and application of pharmaceutical substances used to treat, manage, or prevent diseases and conditions in equine patients. This field involves understanding the pharmacokinetics and pharmacodynamics of various drugs, including their absorption, distribution, metabolism, and excretion in horses. Medications commonly administered to horses include non-steroidal anti-inflammatory drugs (NSAIDs), antibiotics, anthelmintics, and sedatives. The appropriate use of these medications is critical for ensuring therapeutic efficacy and minimizing adverse effects. Research in this area focuses on dosage optimization, drug interactions, resistance development, and withdrawal times to ensure both the health of the horse and compliance with regulatory standards. This page aggregates peer-reviewed studies and scholarly articles that explore the pharmacological aspects, clinical applications, and regulatory considerations of equine medications.
Use of carprofen in racehorses.
The Veterinary record    November 19, 1997   Volume 141, Issue 15 400 
Balmer T, Curwen A.No abstract available
Aerosol deposition in equine lungs following ultrasonic nebulisation versus jet aerosol delivery system.
Equine veterinary journal    November 5, 1997   Volume 29, Issue 5 388-393 doi: 10.1111/j.2042-3306.1997.tb03145.x
Votion D, Ghafir Y, Munsters K, Duvivier DH, Art T, Lekeux P.Therapeutic aerosols pay an increasing role in the treatment of equine respiratory disorders. This route of delivery permits concentration of significant amounts of drugs at the site of action without unwanted high systemic concentration and resultant side effects. The efficiency of such a topical therapy depends on the quantity of inhaled drugs deposited in the lungs and, for some drugs, on the proportion retained in specific parts of the lungs. The objective of this study was to define and to compare quantitative (dose deposited) and qualitative (regional distribution) deposition of an aeros...
Disposition of flunixin after intramuscular administration of flunixin meglumine to horses.
Journal of veterinary pharmacology and therapeutics    August 1, 1997   Volume 20, Issue 4 330-332 doi: 10.1046/j.1365-2885.1997.00069.x
Dyke TM, Sams RA, Cosgrove SB.No abstract available
Clinical remission of granulomatous enteritis in a standardbred gelding following long-term dexamethasone administration.
Equine veterinary journal    March 1, 1997   Volume 29, Issue 2 164-167 doi: 10.1111/j.2042-3306.1997.tb01662.x
Duryea JH, Ainsworth DM, Mauldin EA, Cooper BJ, Edwards RB.No abstract available
[Kinetics of elimination of diazepam after intravenous injection in horses].
DTW. Deutsche tierarztliche Wochenschrift    January 1, 1997   Volume 104, Issue 1 22-25 
Shini S, Klaus AM, Hapke HJ.Diazepam is used in veterinary medicine as sedative and pre-anaesthetic agent. This publication describes the plasma-concentration time curve for diazepam and its metabolite in horses suffering from colic after intravenous application as pre-anaesthetic agent. Elimination half-life (t1/2 beta) after a dose of 0.05-0.08 mg/kg (30-50 mg Diazepam per horse) was 7.5 to 13.2 h. Total clearance (Cltot) between 1.86 and 3.44 ml/min/kg was detected and apparent volume of distribution in steady state (Vdiss) was 1.98 to 2.25 l/kg. Diazepam was still found in serum after 24 h. The metabolite oxazepam co...
Ultrasound spirometry in the horse: a preliminary report on the method and the effects of xylazine and lobeline hydrochloride medication.
Schweizer Archiv fur Tierheilkunde    January 1, 1997   Volume 139, Issue 12 558-563 
Herholz C, Tschudi P, Gerber H, Moens Y, Straub R.A new computerised ultrasound-based spirometry system according to Buess et al. (1995) modified by a double flow measurement facility was used to study pulmonary function in healthy horses and horses affected with subclinical and manifest chronic bronchiolitis (CB). The horses were first evaluated at rest without any medication. On another occasion all horses were tested following i.v. administration of xylazine (0.4 mg/kg) and following i.v. administration of lobeline hydrochloride (l.hy.; 0.2 mg/kg) to evaluate the effect of xylazine and l.hy. on different spirometric variables. Ultrasound-b...
Asks for source and dosage formulation of pentoxifylline used in equids.
American journal of veterinary research    October 1, 1996   Volume 57, Issue 10 1409 
Boucher JH.No abstract available
Factors associated with gastric lesions in thoroughbred racehorses.
Equine veterinary journal    September 1, 1996   Volume 28, Issue 5 368-374 doi: 10.1111/j.2042-3306.1996.tb03107.x
Murray MJ, Schusser GF, Pipers FS, Gross SJ.Gastroscopic examinations were performed on 67 Thoroughbred horses in training at a race track and repeat examinations performed in 35 horses, 2 to 3 months later. Horses were age 2-9 years and included 16 two-year-olds, 32 three-year-olds and 19 horses > or = 4-years-old. Forty-two of the 67 horses had raced within the 2 months before the initial examination and the remaining 25 horses were in training. Sixty-two of the 67 horses (93%) had one or more lesions present in the gastric mucosa and lesions were present in all of the 42 horses that had raced. Thirty-two of the 35 horses, examined...
The motto of necessity: imaging modalities for orthopaedic prognosis.
Equine veterinary journal    September 1, 1996   Volume 28, Issue 5 341-343 doi: 10.1111/j.2042-3306.1996.tb03102.x
Pilsworth RC, Riggs CM.No abstract available
Disposition of single-dose oral enrofloxacin in the horse.
Journal of veterinary pharmacology and therapeutics    August 1, 1996   Volume 19, Issue 4 316-319 doi: 10.1111/j.1365-2885.1996.tb00057.x
Langston VC, Sedrish S, Boothe DM.No abstract available
Pergolide treatment for Cushing’s syndrome in a horse.
The Veterinary record    July 13, 1996   Volume 139, Issue 2 41-43 doi: 10.1136/vr.139.2.41
Muñoz MC, Doreste F, Ferrer O, González J, Montoya JA.A 16-year-old, male, Hanoverian horse had a three-month history of weight loss, hirsutism and polyuria/polydypsia. Examinations revealed neutrophilia, lymphopenia, hyper glycaemia and abnormalities in hepatic function. A tentative diagnosis of hyperadrenocorticism was made. The results of thyroid-releasing hormone and combined dexamethasone suppression and ACTH stimulation tests suggested the presence of a pituitary adenoma. The horse was treated with pergolide and beneficial clinical and biochemical responses were observed within one to six months.
Targetting the use of beta 2-adrenoceptor agonists to meet physiological and rule book requirements.
Equine veterinary journal    July 1, 1996   Volume 28, Issue 4 250-252 doi: 10.1111/j.2042-3306.1996.tb03085.x
Nolan A, McKellar Q.No abstract available
Character and duration of pharmacological effects of intravenous isoxsuprine.
Equine veterinary journal    July 1, 1996   Volume 28, Issue 4 320-326 doi: 10.1111/j.2042-3306.1996.tb03096.x
Harkins JD, Mundy GD, Stanley S, Woods WE, Sams RA, Richardson DR, Tobin T.Isoxsuprine is a therapeutic medication used to treat navicular disease and other lower limb problems in horses and is one of the more frequently detected therapeutic agents in racing horses. In a crossover study, horses were administered isoxsuprine i.v. to determine the character and duration of its pharmacological effects. Isoxsuprine significantly increased heart rate 5-150 min following injection. Unrestrained activity following isoxsuprine treatment was significantly greater than control activity for 105 min after treatment. There was an apparent, although statistically nonsignificant, i...
[The concentration changes of different phenylbutazone formulations in horse plasma].
DTW. Deutsche tierarztliche Wochenschrift    June 1, 1996   Volume 103, Issue 6 224-230 
Keller H, Hashem A.In a study in the horse, the disposition, the pharmacokinetic parameters and the absorption rates of 3 formulations of phenylbutazone (injection solution, powder and paste suspension) have been determined. After i.v. injection, the half-life time of phenylbutazone has been determined to be 6.6-6.7 h. After oral administration, the absorption of phenylbutazone was found to be faster after administration via stomach tube than after direct application into the mouth. The absorption rat constant of the paste suspension was found to be higher than that of the powder (1.797-2.304 h-1 vs. 0.656-1.197...
[Demonstration of activity of two potentiated sulfonamides in feces of horses after oral or intravenous administration].
Tierarztliche Praxis    June 1, 1996   Volume 24, Issue 3 261-269 
Fey K, Weiss R, Sasse HH.Both, the oral and intravenous application of two trimethoprim-potentiated sulfonamides induced measurable antibacterial activities in the feces of horses. With regard to the risk of antibiotic-induced alterations of the gastrointestinal flora, the route of application of potentiated sulfonamides seems to be of minor importance. The antibiotics used were Sulfadimethoxine/Trimethoprim (Trafigal 30% ad us. vet.) for oral and Sulfadoxine/Trimethoprim (Borgal 24% ad us. vet., both Hoechst AG, Frankfurt) for intravenous application. As recommended, both drugs were given in a dose of 20 mg per kg bo...
Pharmacokinetics and tolerance of florfenicol in Equidae.
Equine veterinary journal    May 1, 1996   Volume 28, Issue 3 209-213 doi: 10.1111/j.2042-3306.1996.tb03774.x
McKellar QA, Varma KJ.Florfenicol was administered to horses and ponies at a dose rate of 22 mg/kg bwt by i.v., i.m. and oral routes. Following i.v. administration it had an elimination half-life of 1.8 ± 0.9 h, a body clearance of 0.4 ± 0.11/h.kg and a volume of distribution at steady-state of 0.7 ± 0.2 1/kg. It was highly bioavailable following i.m. (81%) and oral (83%) administration. Less than 15% of the administered dose was excreted unchanged in the urine during the 30 h following administration. Animals treated with florfenicol had elevated bilirubin concentrations. Florfenicol was well tolerated by anima...
Oral ivermectin paste for the treatment of chorioptic mange in horses.
The Veterinary record    December 23, 1995   Volume 137, Issue 26 661-663 
Littlewood JD, Rose JF, Paterson S.A single blind controlled clinical trial of oral ivermectin paste at a dose rate of 0.1 mg/kg daily for seven days for the treatment of chorioptic mange in horses was carried out. There was a statistically significant reduction in the numbers of mites in the samples taken from the treated horses compared with the untreated horses, but the mites were not eliminated from all the treated animals. Two further groups of horses were treated, one at a dose rate of 0.1 mg/kg daily for 10 days and the other with two doses of 0.2 mg/kg given two weeks apart. There were no statistically significant diffe...
Guidelines for the use of medicines in equine animals. British Equine Veterinary Association.
The Veterinary record    November 18, 1995   Volume 137, Issue 21 547 doi: 10.1136/vr.137.21.547-b
Ricketts SW, Greet TR.No abstract available
Comparison of moxidectin with ivermectin and pyrantel embonate for reduction of faecal egg counts in horses.
The Veterinary record    November 11, 1995   Volume 137, Issue 20 516-518 doi: 10.1136/vr.137.20.516
Taylor SM, Kenny J.No abstract available
Changing concepts of COPD.
Equine veterinary journal    November 1, 1995   Volume 27, Issue 6 402-403 doi: 10.1111/j.2042-3306.1995.tb04417.x
Mair TS.No abstract available
Controlled efficacy study of the bioequivalence of Strongid C and generic pyrantel tartrate in horses.
Veterinary parasitology    November 1, 1995   Volume 60, Issue 1-2 83-102 doi: 10.1016/0304-4017(94)00766-6
Valdez RA, DiPietro JA, Paul AJ, Lock TF, Hungerford LL, Todd KS.The bioequivalence of Strongid C and generic pyrantel tartrate was determined in a controlled study using 30 horses with naturally acquired endoparasitic infections. Three horses were randomly allocated to each of ten replicates based on quantitative nematode and ascarid egg counts and fecal larvae culture results. Horses within each replicate were randomly assigned to one of three treatment groups. Horses in Treatment Group 1 received only oats; horses in Treatment Group 2 received generic pyrantel tartrate pellets (2.65 mg pyrantel tartrate kg-1) mixed with oats; horses in Treatment Group 3 ...
Use of cisapride in the resolution of pelvic flexure impaction in a horse.
The Canadian veterinary journal = La revue veterinaire canadienne    October 1, 1995   Volume 36, Issue 10 624-625 
Steinebach MA, Cole D.No abstract available
Pharmacokinetics of oxytetracycline administered intravenously to 4 to 5-day-old foals.
Journal of veterinary pharmacology and therapeutics    October 1, 1995   Volume 18, Issue 5 375-378 doi: 10.1111/j.1365-2885.1995.tb00607.x
Papich MG, Wright AK, Petrie L, Korsrud GO.No abstract available
The pharmacological basis of cardiac drug selection for use in horses.
Equine veterinary journal. Supplement    September 1, 1995   Issue 19 97-100 doi: 10.1111/j.2042-3306.1995.tb04995.x
Baggot JD.No abstract available
An ethicist’s commentary on whether veterinarians should prescribe medications that are neither therapeutic nor prophylactic to increase productivity.
The Canadian veterinary journal = La revue veterinaire canadienne    September 1, 1995   Volume 36, Issue 9 535-536 
Rollin BE.No abstract available
Cyclosporin-responsive keratoconjunctivitis in the cat and horse.
The Veterinary record    August 12, 1995   Volume 137, Issue 7 170-171 doi: 10.1136/vr.137.7.170
Read RA, Barnett KC, Sansom J.No abstract available
Efficacy of pyrantel embonate and praziquantel against the equine tapeworm Anoplocephaloides mamillana.
The Veterinary record    July 8, 1995   Volume 137, Issue 2 45-46 doi: 10.1136/vr.137.2.45
Proudman CJ, Swan JD, Trees AJ.No abstract available
Practical implications of pharmacokinetic and pharmacodynamic (PK/PD) modelling of drug dose regimens.
Equine veterinary journal    July 1, 1995   Volume 27, Issue 4 245-246 doi: 10.1111/j.2042-3306.1995.tb03071.x
Baggot JD.No abstract available
[Off-label use of lincomycin hydrochloride in 2 horses. Dysbacteriosis and fatal complications due to inadequate symptomatic therapy].
Tijdschrift voor diergeneeskunde    June 15, 1995   Volume 120, Issue 12 361-363 
van Miert AS.A lawyer inquired about the possible harmful effects of 'off-label use' of lincomycin in two trotting horses. From information in the relevant dossier it could be concluded that there was no direct indication to use antibiotics. In addition, mistakes were made in the medicinal treatment of horses, namely, the off-label use of lincomycin without prior consultation with the manufacturer, fluid and electrolyte replacement therapy not continued for long enough, and incorrect use of antipyretic analgesics. The intravenous administration of gentamicin to dehydrated patients is permissible only in co...
Pharmacokinetics, nephrotoxicosis, and in vitro antibacterial activity associated with single versus multiple (three times) daily gentamicin treatments in horses.
American journal of veterinary research    May 1, 1995   Volume 56, Issue 5 613-618 
Godber LM, Walker RD, Stein GE, Hauptman JG, Derksen FJ.Once-daily administration of aminoglycosides may be a safe and effective therapeutic regimen, on the basis of the microbiologic and pharmacokinetic characteristics of these antibiotics. This study was designed to determine serum and tissue concentrations following i.v. administration of gentamicin, at dosages of 6.6 mg/kg of body weight, every 24 hours, and 2.2 mg/kg, every 8 hours, for 10 days in adult horses. Nephrotoxicosis from these dosage regimens also was compared, and microbiologic effects, including postantibiotic effects, were determined with various concentrations of gentamicin agai...
1 … 19 20 21 22 23 … 42